Silexion Therapeutics Corp (NASDAQ:SLXN) shares, rose in value on Thursday, April 16, with the stock price down by -2.75% to the previous day’s close as strong demand from buyers drove the stock to $0.75.
Actively observing the price movement in the last trading, the stock closed the session at $0.77, falling within a range of $0.75 and $0.798. The value of beta (5-year monthly) was 0.055. Referring to stock’s 52-week performance, its high was $122.02, and the low was $0.57. On the whole, SLXN has fluctuated by -32.43% over the past month.
With the market capitalization of Silexion Therapeutics Corp currently standing at about $6.52 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-17.
The stock’s technical analysis shows that the price of SLXN currently trading nearly -21.22% and -31.44% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.60, while the 7-day volatility ratio is showing 7.43% which for the 30-day chart, stands at 10.84%. Furthermore, Silexion Therapeutics Corp (SLXN)’s beta value is 0.20, and its average true range (ATR) is 0.12.
A comparison of Silexion Therapeutics Corp (SLXN) with its peers suggests the former has fared considerably weaker in the market. SLXN showed an intraday change of -2.75% in last session, and over the past year, it shrunk by -99.22%%.
Data on historical trading for Silexion Therapeutics Corp (NASDAQ:SLXN) indicates that the trading volumes over the past 10 days have averaged 0.22 and over the past 3 months, they’ve averaged 13.48 million. According to company’s latest data on outstanding shares, there are 8.69 million shares outstanding.
Nearly 9.05% of Silexion Therapeutics Corp’s shares belong to company insiders and institutional investors own 7.18% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.38 million shares as on 2025-03-31, resulting in a short ratio of 0.08. According to the data, the short interest in Silexion Therapeutics Corp (SLXN) stood at 457.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.98 million. The stock has fallen by -62.69% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SLXN stock heading into the next quarter.
